DRZID
AMGN icon

DePrince Race & Zollo Inc (DRZ)’s Amgen AMGN Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-846,990
Closed -$100M – 282
2014
Q2 		$100M Buy
+846,990
New +$98M 1.18% 11

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s AMGN Position: Q3 2014 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Amgen (AMGN) in Q3 2014, closing a stake of 846,990 shares — an estimated $100M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in AMGN in Q2 2014 and held it in 1 quarter. The position peaked at $100M in Q2 2014. 1,223 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Amgen position as of Q3 2014 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 846,990 Amgen shares in Q3 2014, an estimated $100M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Amgen in Q2 2014 and held it in 1 quarter.
  • DePrince Race & Zollo Inc (DRZ)'s Amgen position peaked at $100M in Q2 2014.
  • 1,223 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.